Candel Therapeutics, Inc. CADL Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s change in lease liabilities?
- Candel Therapeutics, Inc. (CADL) reported change in lease liabilities of -$108K in Q1 2026.
- How has Candel Therapeutics, Inc.'s change in lease liabilities changed year-over-year?
- Candel Therapeutics, Inc.'s change in lease liabilities increased by 20.6% year-over-year, from -$136K to -$108K.
- What is the long-term trend for Candel Therapeutics, Inc.'s change in lease liabilities?
- Over 3 years (2022 to 2025), Candel Therapeutics, Inc.'s change in lease liabilities has grown at a 3.1% compound annual growth rate (CAGR), from -$464K to -$509K.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.